Personalis is a leader in population sequencing and cancer genomics, with a focus on data, scale, efficiency and quality. Personalis operates one of the largest sequencing operations globally and is currently the sole sequencing provider to the VA Million Veteran Program (MVP). In oncology, Personalis is transforming the development of next-generation therapies by providing more comprehensive molecular data about each patient’s cancer and immune response. The Personalis® ImmunoID NeXT Platform® is designed to adapt to the complex and evolving understanding of cancer, providing its biopharmaceutical customers with information on all of the approximately 20,000 human genes, together with the immune system, from a single tissue sample. The Personalis Clinical Laboratory is GxP-aligned as well as CLIA’88-certified and CAP-accredited.

Biotechnology

Health Care

Health Diagnostics

Personalis

Christopher Hall

Stephen Fairclough

Sherry Kan

Deepshikha Bhandari

Gail Stanley

Aaron Tachibana

Stephen Moore

Stephane Mouradian

Richard Chen

James Azzaro

Robert Bruce

The leadership team at Personalis has a wealth of experience in the healthcare industry. They have held positions at Clinical Genomics, Lihua International, Inc., and China North East Petroleum Holdings, Ltd. They have also served on the board of Immucell Corporation and have been a venture partner at New Leaf Venture Partners and an advisory board member at Arboretum Ventures. Additionally, they have served as a board observer at Twist Bioscience and Boreal Genomics. They hold degrees from Princeton University, Yale School of Management, and the University of Wisconsin - Madison.

Leadership Team

Board of Directors

CEO and Executive Team

Leadership Team

About

Team members

Other teams at Personalis

Board of Directors

CEO and Executive Team